Christopher Bricogne
Christopher Bricogne
Dirección de correo verificada de
TítuloCitado porAño
PD‐L1 co‐stimulation contributes to ligand‐induced T cell receptor down‐modulation on CD8+ T cells
K Karwacz, C Bricogne, D MacDonald, F Arce, CL Bennett, M Collins, ...
EMBO molecular medicine 3 (10), 581-592, 2011
PD-L1/PD-1 co-stimulation, a brake for T cell activation and a T cell differentiation signal
T Liechtenstein, I Dufait, C Bricogne, A Lanna, J Pen, K Breckpot, ...
Journal of clinical & cellular immunology, 2012
PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy
K Karwacz, F Arce, C Bricogne, G Kochan, D Escors
Oncoimmunology 1 (1), 86-88, 2012
Immune modulation by genetic modification of dendritic cells with lentiviral vectors
T Liechtenstein, N Perez-Janices, C Bricogne, A Lanna, I Dufait, ...
Virus research 176 (1-2), 1-15, 2013
Retroviral and lentiviral vectors for the induction of immunological tolerance
I Dufait, T Liechtenstein, A Lanna, C Bricogne, R Laranga, A Padella, ...
Scientifica 2012, 2012
On the Mechanism of T cell receptor down-modulation and its physiological significance
D Escors, C Bricogne, F Arce, G Kochan, K Karwacz
The journal of bioscience and medicine 1 (1), 2011
Targeted lentiviral vectors: current applications and future potential
C Goyvaerts, T Liechtenstein, C Bricogne, D Escors, K Breckpot
Gene Therapy-Tools and Potential Applications, 2013
TMEM16F activation by Ca 2+ triggers plasma membrane expansion and directs PD-1 trafficking
C Bricogne, M Fine, PM Pereira, J Sung, M Tijani, Y Wang, R Henriques, ...
Scientific reports 9 (1), 619, 2019
Critical mass hypothesis of T-cell responses and its application for the treatment of T-cell lymphoma
C Bricogne, R Laranga, A Padella, I Dufait, T Liechtenstein, K Breckpot, ...
Hodgkin’s and T-cell lymphoma: Diagnosis, Treatment Options and Prognosis …, 2012
Lentiviral Vectors in Immunotherapy
I Dufait, T Liechtenstein, A Lanna, R Laranga, A Padella, C Bricogne, ...
Gene Therapy-Tools and Potential Applications, 2013
Massive surface membrane expansion without involvement of classical exocytic mechanisms.
M Fine, C Bricogne, DW Hilgemann
bioRxiv, 249284, 2018
Plasma Membrane Dynamics Regulating the PD-1/PD-L1 Pathway
CC Bricogne
UCL (University College London), 2015
Interference with PD-L1/PD-1 co-stimulation results in effective anti-tumour immunity by preventing ligand-induced T cell receptor down-modulation in effector CD8 T cells
D Escors, T Liechtenstein, N Perez-Janices, A Lanna, C Bricogne, ...
HUMAN GENE THERAPY 24 (12), A170-A170, 2013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–13